• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚砜 TS-UL 和 PMMA NF-U 透析器与扩展血液透析和后稀释血液透析滤过的评估与比较。

Evaluation and comparison of polysulfone TS-UL and PMMA NF-U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration.

机构信息

Department of Nephrology, Hospital Clínic Barcelona, Barcelona, Spain.

Department of Medicine, University of Barcelona, Barcelona, Spain.

出版信息

Artif Organs. 2021 Sep;45(9):E317-E323. doi: 10.1111/aor.13968. Epub 2021 May 20.

DOI:10.1111/aor.13968
PMID:33908062
Abstract

Toray has created a new generation of dialyzers, the polysulphone (TS) UL series, and polymethylmethacrylate (PMMA) NF-U series, which offer enhanced efficacy over the previous TS-S series and NF-H series. The aim of this study was to evaluate the safety and efficacy of these dialyzer series versus contrasted expanded hemodialysis (HDx) and postdilution hemodiafiltration (HDF). We conducted a prospective study in 12 patients. Each patient underwent six dialysis sessions: FX80 Cordiax in HD, Toraysulfone TS-1.8 UL in HD, Theranova 400 in HDx, polymethylmethacrylate (PMMA) NF-2.1 U in HDF, Toraysulfone TS-2.1 UL in HDF, and FX80 Cordiax in HDF. The removal ratios (RRs) of urea, creatinine, ß -microglobulin, myoglobin, prolactin, α -microglobulin, α -acid glycoprotein, and albumin were compared intraindividually. Dialysate albumin loss was also measured. The RRs for β -microglobulin, myoglobin, prolactin, α -microglobulin, and α -acid glycoprotein were higher with the TS-2.1 UL and FX80 Cordiax dialyzers in HDF than those obtained with HD treatments and NF-2.1 U in HDF. The β -microglobulin, myoglobin, and prolactin RRs were also higher with HDx than those obtained with HD treatments. The myoglobin and prolactin RRs were higher with TS-1.8 UL in HD than those obtained with helixone dialyzers in HD. Dialysate albumin loss was less than 3 g in all situations except in TS-2.1 UL in HDF. The highest global removal score values were obtained with the TS-2.1 UL and helixone dialyzers in HDF. Significant differences were found between all study situations. In conclusion, the new generation dialyzers, Toraysulfone TS Series UL and PMMA NF-U series, show excellent behaviour and tolerance in HD and HDF, representing an upgrade versus their predecessor series. The higher permeability of the TS UL series has been proven with higher efficiency in HD and maximum performance in HDF. The new PMMA NF-U series allows the use of HDF with good efficiency and complete safety.

摘要

东丽公司创造了新一代的透析器,聚砜(TS)UL 系列和聚甲基丙烯酸甲酯(PMMA)NF-U 系列,与之前的 TS-S 系列和 NF-H 系列相比,具有更高的疗效。本研究旨在评估这些透析器系列与对照的扩展血液透析(HDx)和后稀释血液透析滤过(HDF)相比的安全性和疗效。我们进行了一项前瞻性研究,纳入了 12 名患者。每位患者接受了 6 次透析:FX80 Cordiax 在 HD 中,Toraysulfone TS-1.8 UL 在 HD 中,Theranova 400 在 HDx 中,聚甲基丙烯酸甲酯(PMMA)NF-2.1 U 在 HDF 中,Toraysulfone TS-2.1 UL 在 HDF 中,FX80 Cordiax 在 HDF 中。比较了个体内尿素、肌酐、ß-微球蛋白、肌红蛋白、催乳素、α-微球蛋白、α-酸性糖蛋白和白蛋白的清除率(RR)。还测量了透析液白蛋白的损失。在 HDF 中,与 HD 治疗和 HDF 中的 NF-2.1 U 相比,TS-2.1 UL 和 FX80 Cordiax 透析器的 β-微球蛋白、肌红蛋白、催乳素、α-微球蛋白和 α-酸性糖蛋白 RR 更高。与 HD 治疗相比,HDx 中的 β-微球蛋白、肌红蛋白和催乳素 RR 更高。与 HD 中的 helixone 透析器相比,TS-1.8 UL 在 HD 中的肌红蛋白和催乳素 RR 更高。除了在 HDF 中的 TS-2.1 UL 中,所有情况下的透析液白蛋白损失均小于 3g。在 HDF 中,TS-2.1 UL 和 helixone 透析器的总体清除评分最高。所有研究情况之间均存在显著差异。总之,新一代透析器,聚砜 TS 系列 UL 和聚甲基丙烯酸甲酯 NF-U 系列,在 HD 和 HDF 中表现出良好的性能和耐受性,与前一系列相比有所升级。TS UL 系列的更高通透性已被证明在 HD 中具有更高的效率,在 HDF 中具有最大的性能。新型 PMMA NF-U 系列允许使用 HDF,具有良好的效率和完全的安全性。

相似文献

1
Evaluation and comparison of polysulfone TS-UL and PMMA NF-U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration.聚砜 TS-UL 和 PMMA NF-U 透析器与扩展血液透析和后稀释血液透析滤过的评估与比较。
Artif Organs. 2021 Sep;45(9):E317-E323. doi: 10.1111/aor.13968. Epub 2021 May 20.
2
High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.替代现行透析器的高通量选择,用于进行高通量血液透析和在线后稀释血液透析滤过。
Artif Organs. 2019 Oct;43(10):1014-1021. doi: 10.1111/aor.13480. Epub 2019 Jun 18.
3
Efficacy and safety of the Clearum dialyzer.Clearum透析器的疗效与安全性。
Artif Organs. 2021 Oct;45(10):1195-1201. doi: 10.1111/aor.13993. Epub 2021 Jun 9.
4
Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer.中等通量 Elisio HX 透析器的疗效和安全性。
Blood Purif. 2023;52(1):68-74. doi: 10.1159/000524644. Epub 2022 May 12.
5
Most recently developed polyester polymer alloy dialyzer: A new medium cut-off membrane?最近开发的聚酯聚合物合金透析器:一种新型的中分子截止膜?
Artif Organs. 2024 Jul;48(7):753-762. doi: 10.1111/aor.14726. Epub 2024 Feb 26.
6
Medium Cut-Off Dialyzer versus Eight Hemodiafiltration Dialyzers: Comparison Using a Global Removal Score.中分子 cutoff 透析器与 8 种血液透析滤过透析器:使用全球清除评分的比较。
Blood Purif. 2019;48(2):167-174. doi: 10.1159/000499759. Epub 2019 Apr 3.
7
Comparison of four medium cut-off dialyzers.四种中通量透析器的比较
Clin Kidney J. 2022 Jul 13;15(12):2292-2299. doi: 10.1093/ckj/sfac167. eCollection 2022 Dec.
8
Comparison of efficacy and safety of the new generation helixone dialyzers.新一代Helixone透析器的疗效与安全性比较。
Nefrologia (Engl Ed). 2024 May-Jun;44(3):354-361. doi: 10.1016/j.nefroe.2024.04.005. Epub 2024 Apr 27.
9
Comparison of Solute Removal Properties Between High-Efficient Dialysis Modalities in Low Blood Flow Rate.在低血流速率下高效透析模式之间溶质清除性能的比较。
Ther Apher Dial. 2020 Aug;24(4):387-392. doi: 10.1111/1744-9987.13440. Epub 2019 Nov 10.
10
Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration.在短程每日在线血液透析滤过中,对高通量聚砜透析器进行再处理不会对溶质清除产生负面影响。
Hemodial Int. 2014 Apr;18(2):473-80. doi: 10.1111/hdi.12126. Epub 2014 Jan 7.

引用本文的文献

1
Latest Trends in Hemodiafiltration.血液透析滤过的最新趋势
J Clin Med. 2024 Feb 16;13(4):1110. doi: 10.3390/jcm13041110.
2
Polymeric Membranes for Biomedical Applications.用于生物医学应用的聚合物膜。
Polymers (Basel). 2023 Jan 25;15(3):619. doi: 10.3390/polym15030619.